Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision LIMERICK, IRELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Johnson & Johnson MedTech*, a global leader in eye health, announced today that its TECNIS PureSee purely refractive presbyopia-correcting lens is now available in EMEA.

下一代镜片采用纯屈光设计，提供不间断的高质量视力利默里克，爱尔兰，2024年2月15日（环球通讯社）——全球眼科健康领导者强生医疗科技公司今天宣布，其TECNIS PureSee纯屈光性老视矫正镜片现已在欧洲、中东和非洲地区上市。

The TECNIS PureSee IOL features a proprietary, purely refractive design that delivers uninterrupted, high-quality, vision with high best-in-category contrast and low-light performance, comparable to a monofocal IOL1,2,3,4. “Cataract surgery is the number one surgery performed globally, with 28 million procedures each year.

TECNIS PureSee IOL采用专有的纯折射设计，可提供不间断的高质量视觉，具有高的最佳对比度和低光性能，可与单焦点IOL1、2、3、4相媲美。“白内障手术是全球首屈一指的手术，每年有2800万次手术。

But only 10-15% of patients are getting advanced optical IOLs specifically designed for astigmatism and presbyopia10,” said Jacqueline Henderson, President Vision, EMEA, Johnson & Johnson. “Today, we’re proud to launch the TECNIS PureSee IOL, giving surgeons and patients the choice of a premium IOL that combines clarity of vision and reduced visual symptoms10.” Today, when choosing an IOL, surgeons and patients must make trade-off decisions.

但只有10%至15%的患者正在接受专门为散光和老视设计的高级光学人工晶状体，”强生公司欧洲、中东和非洲地区总裁杰奎琳·亨德森（JacquelineHenderson）说。“今天，我们很荣幸推出TECNIS PureSee人工晶状体，让外科医生和患者可以选择一种结合了视力清晰和减少视觉症状的优质人工晶状体10。”今天，在选择人工晶状体时，外科医生和患者必须做出权衡决定。

For example, you can have a lens that offers clear sight at all distances without spectacles, but at the price of possible glares and halos. TECNIS PureSee combats these issues and improves the overall outcomes for both patients and surgeons. 2,3,8,10,11 “A key concern for patients who chose a premium IOL is whether their vision correction surgery meets their expectations both in regard to the level of spectacle independence** and quality of vision.

例如，你可以拥有一个不戴眼镜的镜头，在任何距离都能提供清晰的视野，但代价是可能产生眩光和光晕。TECNIS PureSee解决了这些问题，并改善了患者和外科医生的整体结果。2,3,8,10,11“选择优质人工晶状体的患者的一个关键问题是，他们的视力矫正手术是否符合他们对眼镜独立性水平**和视力质量的期望。

My early experience with the TECNIS PureSee IOL has been extremely positive and has consistently delivered on these expectations resulting in very happy patients,” said Dr. Francesco Carones, Medical Director & Physician CEO Advalia Vision, Milano, .

我早期使用TECNIS PureSee人工晶状体的经验非常积极，并始终满足了这些期望，使患者感到非常幸福，”米兰Advalia Vision医疗总监兼医生兼首席执行官Francesco Carones博士说。

Attachment

附件

TECNIS PureSee IOL

TECNIS PureSee IOL